Vor Biopharma Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $396.5M | $81.9M | $31.4M | $57.7M | $119.8M | $48.5M |
| Accounts Receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $458.1M | $96.5M | $140.8M | $237.0M | $214.4M | $49.1M |
| Property, Plant & Equipment | $533.0K | $6.6M | $10.1M | $12.6M | $6.9M | $4.7M |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — |
| Total Assets | $464.1M | $142.9M | $198.1M | $299.4M | $242.6M | $75.9M |
| Liabilities | ||||||
| Accounts Payable | $5.1M | $1.5M | $815.0K | $1.8M | $1.5M | $2.4M |
| Total Current Liabilities | $25.2M | $18.6M | $15.6M | $13.1M | $10.2M | $10.2M |
| Long-Term Debt | — | — | — | — | — | — |
| Total Liabilities | $628.4M | $46.2M | $47.4M | $48.8M | $26.3M | $27.6M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-1.15B | $-457.0M | $-340.1M | $-222.2M | $-130.1M | $-61.2M |
| Total Stockholders' Equity | $-164.3M | $96.7M | $150.7M | $250.6M | $216.3M | $-59.1M |